Skip to content

Integrated Genetic and Functional Analysis of the Influence of Menstrual Hygiene Products on Female Health

Integrated Genetic and Functional Analysis of the Influence of Menstrual Hygiene Products on Female Health

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06519799
Acronym
Luna
Enrollment
100
Registered
2024-07-25
Start date
2024-08-01
Completion date
2025-10-31
Last updated
2024-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menstrual Discomfort, Vaginal Disease

Keywords

menstrual health, intimate health

Brief summary

Women's reproductive health has attracted increasing attention in recent years, including in the field of microbiology. Vaginal infections, such as vulvovaginal candidiasis, bacterial vaginosis and aerobic vaginitis, are common and a huge burden on our society. The vaginal microbiome is important in the prevention of these infections, in fertility and for healthy pregnancies. The composition, and therefore the 'health' of the vaginal microbiome, is influenced by many internal and external factors, including intimate health. However, it is not yet known how intimate health, and specifically the use of menstrual hygiene products, affects the microbiome and women's intimate comfort and health. In this study, the researchers aim to understand the influence of 5 menstrual hygiene products (tampon, menstrual cup, menstrual pad and 2 types of menstrual underwear) on women's intimate health (n = 100). First, this will be evaluated at the microbiome level, focusing on the female intimate microbiome, consisting of the skin in the groin, vulvar and vaginal microbiome. These sites are all closely linked and are affected in vaginal infections or by contact with menstrual hygiene products. Second, in addition to the direct impact on the microbiome, the impact on the participant's immune system will be evaluated, as some well-known menstrual hygiene products can cause irritation and inflammation. As a third goal, participants will assess the comfort and usability of each menstrual hygiene product and provide data on their lifestyle and other factors that may influence our results. The main goal is to investigate and define the impact of menstrual hygiene products on women's intimate health so that women can make an informed choice. In a first phase participants (n = 1500) will fill in a survey containing questions on general health, lifestyle and menstrual health. Based on these responses a selection of 100 participants will be made by the researchers to participate in the intervention trial.

Interventions

OTHERMenstrual hygiene products

The influence on the intimate health of each product will be evaluated. As you can't not use a menstrual product during menstruation, no control group is included

Sponsors

Universiteit Antwerpen
CollaboratorOTHER
Research Foundation Flanders
CollaboratorOTHER
University Hospital, Antwerp
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

As the intervention is the use of a menstrual product, no masking is possible.

Intervention model description

Each participant will wear all 5 menstrual products in a randomized order.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* female * contraception: combination pill with stop week or no hormonal contraception * premenopausal * Dutch-speaking living in Belgium * regular menstrual cycle (if no hormonal contraception)

Exclusion criteria

* Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Beta diversity of the vaginal microbiomeEach month for 3 samplepoints until study completion, an average of 6 monthsThis measure describes the taxonomic diversity between samples, a higher diversity is associated with a less healthy vaginal microbiome. Beta diversity within a participant over all products will be calculated as a stability measure. This will be defined for each participant comparing the baseline samples (right before menstruation) to the sample during and after menstruation. Comparison will be made between different menstrual hygiene products.

Secondary

MeasureTime frameDescription
relative abundance of eigentaxaEach month for 3 samplepoints until study completion, an average of 6 monthsThe relative abundance of some eigentaxa such as Lactobacillus crispatus will be looked at, as this is known to be associated with some menstrual products. The relative abundance at each samplepoint will be evaluated at the end of the study, comparison will be made between the different menstrual hygiene products.
comfort and ease of usePeriodically, after menstruation once a month.the participants will answer evaluate the comfort and ease of use of each product, during the survey at the timepoint after each menstruation for each product.
alfa diversity of the vaginal microbiomeEach month for 3 samplepoints until study completion, an average of 6 monthsthis measure describes the taxonomic diversity within a sample. The alfa diversity within a participant over all products will be calculated as a measure of stability. This will be defined for each participant comparing the baseline samples (right before menstruation) to the sample during and after menstruation. Comparison will be made between different menstrual hygiene products.
both alfa and beta diversity of the vulvar and groin skin microbiomeEach month for 3 samplepoints until study completion, an average of 6 monthsthese measures describe the taxonomic diversity. Comparison will be made between different menstrual hygiene products.

Countries

Belgium

Contacts

Primary ContactVeronique Verhoeven, Professor
veronique.verhoeven@uantwerpen.be+3232652518
Backup ContactSarah Lebeer, Professor
sarah.lebeer@uantwerpen.be+3232653285

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026